Mauritius-based entity sells Rs 289 crore value shares in Emcure Prescription drugs through block deal; Norges Financial institution acquirer
Emcure Prescription drugs witnessed a block deal on Wednesday during which a Mauritius-based funding entity BC Investments IV Restricted bought...
